PCME is an accredited provider specializing in innovative continuing medical education solutions.
PCME is an accredited provider specializing in innovative continuing medical education solutions.
Michael D. Ezekowitz, MBChB, FRCP, FAHA, DPhil, FACC
Professor and Vice President
Lankenau Institute for Medical Research
Vice President, Clinical Research
Main Line Hospitals
Wynnewood, PA
Michael D. Ezekowitz graduated from the University of Cape Town Medical School in 1970. After his residency, he proceeded to London University (Imperial College) on a British Council Fellowship and was awarded a DPhil degree in 1976. His fellowship in Cardiology was at Johns Hopkins Hospital and his first faculty appointment was at the University of Oklahoma. In 1982, he was recruited to Yale University School of Medicine as an Associate Professor and was awarded tenure in 1990 and an honorary Master's Degree. In 2000 he moved to Philadelphia as the June F. Klinghoffer Professor and Chairman of Medicine at Drexel University School of Medicine. He is now the Vice President of Lankenau Institute for Medical Research (LIMR) and Vice President of Clinical Research, Main Line Hospitals.
Dr. Ezekowitz's research interests include the vascular biology of the arterial wall and thrombosis and thromboembolic disease, particularly as it relates to atrial fibrillation. He and Dr. Sam Bridges and colleagues designed the first double-blind study of coumadin and proved its benefit in patients with non-valvular atrial fibrillation, as published in the New England Journal of Medicine in 1990. Dr. Ezekowitz's current interests in atrial fibrillation center on the etiology of low anticoagulation rates among eligible patients with atrial fibrillation and on the study of new drugs that will prove to be more user friendly than coumadin. He has presented more than 100 national and international invited lectures and been the recipient of large federal and industrial grants to support his basic and clinical research. He has published more than 300 papers and abstracts and has written a book on cardiac sources of systemic embolism. He is on the Editorial Board of Circulation, American Journal of Non-Invasive Cardiology, Journal of Cardiovascular Pharmacology and Therapeutics, Heart Disease: A Journal of Cardiovascular Medicine, and American Journal of Cardiology. He reviews for the New England Journal of Medicine and is an active non-invasive clinical cardiologist. He has led 14 multi-center clinical trials.
